What Researchers Did
This review summarized adjunct methods, including hyperbaric oxygen therapy, maggot therapy, and platelet-rich plasma therapy, for the standard treatment of diabetic foot ulceration.
What They Found
Preclinical and clinical trials indicated that these adjunct methods may reduce the time of therapy for diabetic foot ulcers. These therapies were also found to potentially decrease short-term morbidity and the risk of major amputation.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers might benefit from these adjunct therapies to potentially heal faster and avoid severe complications. Discussing these options with their healthcare provider could help determine if they are suitable additions to standard care.
Canadian Relevance
This review does not have a direct Canadian connection as it was not conducted in Canada nor focused on Canadian populations.
Study Limitations
A limitation is that this review summarizes existing evidence and does not present new primary data or definitive clinical trial results.